{'fraction_non_alphanumeric': 0.04675036663447437, 'fraction_numerical': 0.026898451192903388, 'mean_word_length': 4.970104633781764, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 1, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat

Background This study tested the hypothesis that double overexpression of miR-19a and miR-20a (dOex-mIRs) in human induced pluripotent stem cell (iPS)-derived mesenchymal stem cells (MSCs) effectively preserved left ventricular ejection fraction (LVEF) in dilated cardiomyopathy (DCM) (i.e., induced by doxorubicin) rat. Methods and results In vitro study was categorized into groups G1 (iPS-MSC), G2 (iPS-MSCdOex-mIRs), G3 (iPS-MSC + H2O2/100uM), and G4 (iPS-MSCdOex-mIRs + H2O2/100uM). The in vitro results showed the cell viability was significantly lower in G3 than in G1 and G2, and that was reversed in G4 but it showed no difference between G1/G2 at time points of 6 h/24 h/48 h, whereas the flow cytometry of intra-cellular/mitochondrial oxidative stress (DCFA/mitoSOX) and protein expressions of mitochondrial-damaged (cytosolic-cytochrome-C/DRP1/Cyclophilin-D), oxidative-stress (NOX-1/NOX2), apoptotic (cleaved-caspase-3/PARP), fibrotic (p-Smad3/TGF-ß), and autophagic (ratio of LC3B-II/LC3BI) biomarkers exhibited an opposite pattern of cell-proliferation rate (all p< 0.001). Adult-male SD rats (n=32) were equally divided into groups 1 (sham-operated control), 2 (DCM), 3 (DCM + iPS-MSCs/1.2 × 106 cells/administered by post-28 day’s DCM induction), and 4 (DCM + iPS-MSCdOex-mIRs/1.2 × 106 cells/administered by post-28 day’s DCM induction) and euthanized by day 60 after DCM induction. LV myocardium protein expressions of oxidative-stress signaling (p22-phox/NOX-1/NOX-2/ASK1/p-MMK4,7/p-JNK1,2/p-cJUN), upstream (TLR-4/MAL/MyD88/TRIF/TRAM/ TFRA6/IKKα/ß/NF-κB) and downstream (TNF-α/IL-1ß/MMP-9) inflammatory signalings, apoptotic (cleaved-PARP/mitochondrial-Bax), fibrotic (Smad3/TGF-ß), mitochondrial-damaged (cytosolic-cytochrome-C/DRP1/cyclophilin-D), and autophagic (beclin1/Atg5) biomarkers were highest in group 2, lowest in group 1 and significantly lower in group 4 than in group 3, whereas the LVEF exhibited an opposite pattern of oxidative stress (all p< 0.0001). Conclusion iPS-MSCdOex-mIRs therapy was superior to iPS-MSC therapy for preserving LV function in DCM rat. Supplementary Information The online version contains supplementary material available at 10.1186/s13287-021-02440-4.

Conclusion: iPS-MSC dOex-mIRs therapy was superior to iPS-MSC therapy for preserving LV function in DCM rat.
Keywords: Dilated cardiomyopathy, Double overexpression of microRNAs, Oxidative stress, Inflammation, Mitochondrial damage Assuredly, idiopathic dilated cardiomyopathy (DCM), a primary non-ischemic cardiac muscle disease, is clearly recognized as the consequence of systolic dysfunction and dilatation of chamber size of the left or both of ventricles [1,2]. In fact, vast data have revealed that this disease accounts for approximately one-third of heart failure (HF) patients and is associated with adverse clinical outcomes and unacceptable high morbidity and mortality [3][4][5][6][7]. Abundant clinical trials and clinical observation studies have shown that HF, caused by different disease entity, is an important cause of morbidity and mortality in industrialized countries, with an estimation up to 5.7 million people affected in the USA [8,9] and 30-50 million patients worldwide [10], and 5-year mortality reaching 50% [11].
Despite remarkable progress has been established in both advanced pharmacological and non-pharmacological modalities to treat DCM-related HF, the number of patients for hospitalization and deaths of HF patients has increased steadily [12][13][14][15][16]. The aforementioned issues [11][12][13][14][15] highlight that the treatment of HF caused by DCM is currently an unmet need, suggesting that to develop a safe and efficacious strategic management for DCM is of utmost importance and urgency to patients and physicians.
Inflammation is believed as a distinctive hallmark of HF [17,18] in circulation and proinflammatory cytokines in the myocardium [17,[19][20][21]. This inflammatory response has been further identified in damaged myocardium during propagation of chronic HF to promote monocyte activation and the further production of cytokines, thus augmenting cardiac dysfunction [22], resulting in myocardial fibrosis and cardiac remodeling [23]. Additionally, studies have previously further displayed that an increased reactive oxygen species (ROS) plays a crucial role in the sudden death of these HF/DCM patients [24][25][26]. Furthermore, plentiful clinical and experimental studies have shown that mitochondrial dysfunction plays a principal role in the histopathological process of heart disease [27][28][29].
Recently, the utilization of human induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) has emerged as an innovative option for regenerative medicine [30,31] and as a therapeutic alternative for various disease entities [32][33][34] mainly through suppressing the inflammation and generation of oxidative stress as well as the immunogenicity [35]. However, a full investigation of the impact of iPSC-MSCs on DCM has not been undertaken. Additionally, we have recently identified that the circulating levels of five anti-apoptotic micro-RNAs (i.e., miR-374a-5p, miR-19a-3p, miR-106b-5p, miR-26b-5p, and miR-20a-5p) were significantly lower in chronic kidney disease (CKD) patients than in healthy subjects [36]. These aforementioned issues raised the hypothesis that double overexpression of miR-19a and miR-20a (dOex-mIRs) in induced pluripotent stem cell (iPS)-derived mesenchymal stem cells (MSCs) (i.e., iPS-MSC dOex-mIRs ) might effectively preserve heart function in DCM rat.

Ethics
All animal procedures were approved by the Institute of Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use Protocol No. 2019061902) and performed in accordance with the Guide for the Care and Use of Laboratory Animals.
Animals were housed in an Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC; Frederick, MD, USA)-approved animal facility in our hospital with controlled temperature and light cycles (24°C and 12/12 light cycle).

Methodology of in vitro study of cell culturing for differentiation of human iPSC into mesenchymal stem cells (MSCs)
The procedure and protocol of human iPSC culture for differentiation into MSCs have been described in our previous study [35] and detailed information was illustrated in supplementary Figure 1. In details, at day 1, the human iPSCs (mTeSR™1; StemCell, #28315) were first washed by 5 mL PBS, followed by 2 mL Accutase (Gibco, #A1110501; Accutase: PBS = 1:1); the incubator reaction continued for 1 min. The 2 mL KO DMEM/F12 (Gibco, #12660012) was added and the cells were collected in 15 mL centrifuge tubes for 5-min duration of centrifuge (200×g). The cells were then cultured in a 10-cm dish for 24 h in mTeSR™1 culture medium.
By day 2, the cells (mTeSR™1) were collected and washed by 5 mL PBS. STEMdiff TM -ACF Mesenchymal Induction Medium (StemCell, #05241) was added to incubator culture and proceeded for 24 h. The STEMdiff TM -ACF Mesenchymal Induction Medium was exchanged once per day from days 1 to 3. This procedure was repeated on days 3 to 6. On days 7 to 21, the procedure was repeated but the culture medium was refreshed every 3 days.
miR-19a-3p and miR-20a-5p were candidates for double overexpression in iPS-MSCs (iPS-MSC dOex-mIRs ) and treatment of DCM in rodent The procedure and protocol were based on our recent report [37]. We had identified that miR-19a-3p and miR-20a-5p were the two most suitable candidates among the five miRNAs (i.e., miR-374a-5p/miR-19a-3p/ miR-106b-5p/miR-26b-5p/miR-20a-5p) to be overexpressed (i.e., transfection) for the purpose of treatment of chronic kidney disease + ischemia-reperfusion animals [37]. In detail, transfections of miR-19a-3p and miR-20a-5p mimics efficiently augmented the miRNA expressions and further decreased related gene expressions. Transfections of mimics (25 nM) were conducted with TransIT-X2 Dynamic Delivery System (Mirus), by following the manufacturer's instruction. The iPS-MSCs were recognized > 80% confluence on the day of transfection. TransIT-X2 reagent was mixed with miRNA mimics for 25 min at room temperature. The miRNA mimics-containing complexes were further distributed into cells. Two days later, relevant expressions of miR-NAs and genes were validated by the real-time qPCR assay.

DCM induction in rodent by doxorubicin (Dox) and animal grouping
Pathogen-free, adult male Sprague-Dawley (SD) rats (n=32) weighing 320-350 g (Charles River Technology, BioLASCO Taiwan Co. Ltd., Taiwan) were utilized in this study. The procedure and protocol of Dox-induced rodent DCM model have been described in detail in our previous report [29]. In detail, the accumulated dose of 12.5 mg per kg at 4 separated time points within 20 days (i.e., once every 5 days) in each rat by intraperitoneal (IP) administration was applied in the present study.
Animals were equally categorized into group 1 (shamcontrol, i.e., by IP administration of 1.0 cc saline four times within 20 days, followed by opening chest wall only at day 28 after DCM induction), group 2 (DCM only), group 3 [DCM + iPS-MSCs/1.2 × 10 6 cells/administered by day 28 after DCM induction), and group 4 (DCM + iPS-MSC dOex-mIRs /1.2 × 10 6 cells/administered by day 28 after DCM induction). The dosage of MSCs in the present study was based on our previous studies [35,38]. In the current study, the animals in each group were euthanized by day 60 and the heart specimen was harvested in each animal for individual study.

Procedure and protocol for iPS-MSCs or iPS-MSC dOex-mIRs implanted into the left ventricular (LV) by day 28 after DCM induction
In detail, all animals were anesthetized by inhalational 2.0% isoflurane and placed in a supine position on a warming pad at 37°C. Under sterile conditions, the heart was exposed by opening the chest wall via a left thoracotomy after intubation with animal ventilatory support. Rats receiving thoracotomy in groups 1 and 2. While iPS-MSCs were implanted into four different regions of the LV myocardium in group 3, the iPS-MSC dOex-mIRs was implanted into four different regions of the LV myocardium in group 4. After the procedure, the thoracotomy wound was closed, and the animals were allowed to recover from anesthesia in a portable animal intensive care unit (Thermo-Care®) for 24 h.

Determinant LVEF by utilizing the transthoracic echocardiography
Transthoracic echocardiography was performed in each group prior to and on days 28 and 60 after DCM induction. The procedure was performed by an animal cardiologist blinded to this experimental design using an ultrasound machine (Vevo 2100, Visualsonics). M-mode standard two-dimensional (2D) left parasternal-long axis echocardiographic examinations were conducted. Left ventricular (LV) internal dimensions [end-systolic diameter (ESD) and end-diastolic diameter (EDD)] were measured at the mitral valve level of the left ventricle, according to the leadingedge method of American Society of Echocardiography, by using at least three consecutive cardiac cycles. The left ventricular ejection fraction (LVEF) was calculated as follows: LVEF (%) = [(LVEDD 3 -LVEDS 3 )/LVEDD 3 ] × 100%.

Immunohistochemical (IHC) and immunofluorescent (IF) studies
The procedures and protocols for IHC and IF examinations were based on our previous reports [35][36][37][38][39]. Briefly, specimens of LV myocardium were utilized for IHC and IF staining, rehydrated paraffin sections were first treated with 3% H 2 O 2 for 30 min and incubated with Immuno-Block reagent (BioSB, Santa Barbara, CA, USA) for 30 min at room temperature. Sections were then incubated with primary antibodies specifically against, 8-hydroxy-2′-deoxyguanosine (8-OHdG), γ-H2AX (1:1000, Abcam), and CD14 (1:200, Thermo Fisher), while sections incubated with the use of irrelevant antibodies served as controls. Three sections of heart specimens from each rat were analyzed. For quantification, three randomly selected HPFs (400× for IF studies) were analyzed in each section.

Histopathological finding of myocardial fibrosis
The procedure and protocol were based on our previous studies [29]. In detail, hematoxylin and eosin and Masson's trichrome staining were utilized for the identification of the LV fibrotic area. Three serial sections of LV myocardium in each animal were prepared at 4 μm thickness by Cryostat (Leica CM3050S). The integrated area (μm 2 ) of fibrosis on each section was calculated using the Image Tool 3 (IT3) image analysis software (University of Texas, Health Science Center, San Antonio, UTHSCSA; Image Tool for Windows, Version 3.0, USA). Three randomly selected high-power fields (HPFs) (100×) were analyzed in each section. After determining the number of pixels in each fibrotic area per HPF, the numbers of pixels obtained from three HPFs were calculated. The procedure was repeated in two other sections of each animal. The mean pixel number per HPF for each animal was then analyzed by calculating all pixel numbers and dividing by 9. The mean integrated area (μm 2 ) of fibrosis in LV myocardium per HPF was obtained using a conversion factor of 19.24 (since 1 μm 2 represents 19.24 pixels).
Additionally, the MTT assay was utilized in the present study to determine the cellular metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity.
Furthermore, the cells were also collected after culturing for Western blot analysis. Finally, qPCR analysis was utilized to assess the success of overexpression of iPS-MSC Oex-mIRs .

Procedure and protocol for measurement of reactive oxygen species (ROS)
The fluorescence and grayscale photos were captured by utilizing the DP controller 2.1.1.183 (Olympus). Grayscale photos for measuring the fluorescence intensity were processed by using Image J 1.37v (National Institutes of Health, USA). Nine grayscale photos from each slide were randomly acquired. As compared with the area of increased fluorescence intensity (IFI), the baseline fluorescence intensity (BFI) (arbitrary unit/400 × high-power field) was defined as the area in myocardium loaded without H 2 DCFDA. Six BFI areas were measured from each grayscale photo, from which 3 BFI areas were randomly chosen. The mean IFI and mean BFI were then calculated. The ratio of IFI to the BFI was determined as the relative fluorescence intensity.
The LV specimen were obtained, frozen rapidly in liquid nitrogen, and then stored at − 80°C.

Statistical analysis
Quantitative data are expressed as mean ± SD. Statistical analyses were performed using SAS statistical software for Windows Version 8.2 (SAS Institute, Cary, NC, USA). One-way ANOVA was conducted followed by Bonferroni multiple comparison post hoc test for comparing variables among groups. A probability value < 0.05 was considered statistically significant.
Next, we assessed the capacity of microRNA transfection into iPS-MSCs by performing the relative quantitative qPCR. The result showed that relative miR-19a-3p and miR-20a-5p were lowest in G3, highest in G2, and significantly higher in G4 than in G1 (Fig. 1), suggesting that not only the miRs were successfully transfected into iPS-MSCs but also further proved that the dOex-mIRs still had a good capacity of transfection into iPS-MSC even in the situation of H 2 O 2 treatment (i.e., oxidative stress). Furthermore, to clarify whether the iPS-MSC dOex-mIRs could offer a better ability to protect the cells against the increments of oxidative stress in cellular and mitochondrial levels as well as the active mitochondria of iPS-MSC dOex-mIRs in the condition of oxidative stress, the flow cytometric analysis was performed. As we expected, the fluorescent intensity of DCFDA (i.e., an indicator of total intracellular oxidative stress) and Mito-SOX (i.e., an indicator of mitochondrial oxidative stress were highest in G3 than in G1 and G2, and those were significantly reversed in G4, whereas these parameters did not differ between G1 and G2 (Fig. 2). On the other hand, the TMRE, an index of membrane potential of mitochondria, was highest in G2, lowest in G3, and significantly lower in G4 than in G1 (Fig. 2). To delineate whether the dOex-mIRs would protect the iPS-MSCs against the H 2 O 2 induced DNA damage and cellular senescence, IF microscope was utilized. The results demonstrated the cellular expression of γ-H2AX (Fig. 2), an indicator of DNA damage, and the positivelystained β-galactosidase (Fig. 4) cells were significantly higher in G3 and G4 than in G1 and G2 and significantly higher in G3 than in G4, but they showed no difference between G1 and G2.
Moreover, by using the Western blot analysis, we investigated the impact of dOex-mIRs on ameliorating the oxidative-stress, mitochondria-damaged, apoptotic and autophagic biomarkers in iPS-MSCs. Again as our expected, the protein expressions of NOX-1 and NOX-2 (two indicators of oxidative stress), protein expressions of cytosolic cytochrome C, cyclophilin D, and DRP1 (three indices of mitochondrial-damaged parameters), protein expression of the ratio of LC3BI/ LC3BII (an indicator of autophagy) (Fig. 3), protein expressions of cleaved caspase 3 and cleaved PARP (two indicators of apoptosis), and protein expressions of Smad3 and TGF-1ß (two indicators of fibrosis) (Fig. 4), were significantly increased in G3 than in G1 and G2, and those were significantly reversed in G4, but they did not differ between G1 and G2, whereas the protein expression of mitochondrial cytochrome (Fig. 3), an indicator of mitochondrial integrity, displayed an opposite pattern of oxidative stress among the four groups.
The serial changes of LVEF and fluorescent intensity of oxidative stress in LV myocardium by day 60 after DCM induction (Fig. 5) By day 0 (i.e., at baseline), the LVEF was similar among the group 1 (sham-operated control), group 2 (DCM only), group 3 [DCM + iPS-MSCs/1.2 × 10 6 ), and 4 (DCM + iPS-MSC dOex-mIRs /1.2 × 10 6 cells). However, by day 28 after DCM induction, the LVEF was significantly higher in group 1 than in groups 2 to 4, but it demonstrated no difference among groups 2 to 4. On the other hand, by day 60 after DCM induction, the LVEF was highest in group 1, lowest in group 2, and significantly higher in group 4 than in group 3, implicating that iPS-MSCs effectively and iPS-MSC dOex-mIRs further effectively preserved heart function in setting of DCM.
Additionally, the IF microscopic finding revealed that the fluorescent intensity of oxidative stress (i.e., by 8-OHdG stain) was highest in group 2, lowest in group 1, and significantly higher in group 3 than in group 4.
Cellular expressions of DNA-damaged and inflammatory biomarkers in LV myocardium by day 60 after DCM induction (Fig. 6) The IF microscopic finding demonstrated that the protein expressions of γ-H2AX+ cells, a DNA-damaged indicator, and CD14+ cells, an indicator of inflammation, were highest in group 2, lowest in group 1, and significantly higher in group 3 than in group 4.
Protein expressions of oxidative stress and mitochondrial damaged biomarkers in LV myocardium by day 60 after DCM induction (Figs. 7 and 8) The protein expressions of NOX-1, NOX-2, and p22 phox, three indicators of oxidative stress, were significantly lower in group 1 than in groups 2 to 4, significantly lower in group 4 than in groups 2 and 3, and significantly lower in group 3 than in group 2 (Fig. 7). Additionally, the protein expressions of cytosolic cytochrome C, cyclophilin D, and DRP1, three indicators of mitochondrial damaged biomarkers, were lowest in  1, highest in group 2, and significantly lower in group 4 than in group 3, whereas the protein expression of mitochondrial cytochrome C, an index of mitochondrial integrity, displayed an opposite pattern of oxidative stress among the four groups (Fig. 7). Our findings, in addition to delineating how the oxidative-stress signaling on damaging the myocardium (Fig. 8), suggested that iPS-MSCs effectively and iPS-MSC dOex-mIRs more effectively protected the mitochondria through attenuating the upregulation of oxidative stress in DCM setting.
Protein expressions of mitogen-activated protein kinase (MAPK) pathway, apoptosis and autophagic biomarkers in LV myocardium by day 60 after DCM induction (Fig. 9) We also assessed the role of MAPK in DCM setting by Western blot. As we expected, the protein expressions of apoptosis signal-regulating kinase 1 (ASK1), p-MMK4, p-MMK7, p-JNK1/2, and p-cJUN, four members of MAP kinase family, were highest in group 2, lowest in group 1, and significantly higher in group 3 than in group 4. Additionally, the protein expressions of mitochondrial Bax, cleaved caspase 3, and cleaved PARP, three indicators of apoptosis, and the protein expressions of Atg5 and Beclin1, two indices of autophagic biomarkers, displayed an identical pattern of MAPK family among the four groups.
Protein expressions of upstream and downstream inflammatory signaling pathways in LV myocardium by day 60 after DCM induction (Figs. 10 and 11) To elucidate the inflammatory signalings in the LV myocardium in the DCM setting, the Western blot was utilized. The result showed that the protein  expressions of TLR4, MyD88, MAL, TRIF, TRAM,  TRAF6, IKKα, IKKß, and p-NF-κß, nine indicators of upstream signaling, and protein expressions of TNF-α, IL-1ß, and MMP-9, three indices of downstream signaling, were lowest in group 1, highest in group 2, and significantly lower in group 4 than in group 3 (Fig. 10). Our findings clearly highlighted the upstream and downstream inflammatory signalings involved in the initiation and propagation of myocardial damage in DCM animals (refer to Fig. 11).

Discussion
This study which investigated the therapeutic impact of dOex-mIRs of iPS-MSCs on protecting the heart against DCM damage yielded several striking implications. First, rather than only single mechanism, this study identified that the underlying mechanisms of DCM caused heart and myocardium dysfunction were quite complicated (refer to Figs. 8  and 11). Second, as compared with the SC group, the LVEF was significantly progressively worsening in DCM only, suggesting our DCM model in rodent was successfully created for the study. Third, the LVEF was significantly preserved by iPS-MSCs and further significantly preserved by iPS-MSC dOex-mIRs in DCM rodent, highlighting that this therapeutic management may be potential in the future for DCM patients, especially when their decompensated HF is refractory to conventional therapy that demands the final resort of heart transplantation.
It is well recognized that no matter how advanced pharmaceutical and accessorily mechanical devices have been utilized for those DCM patients with end-stage decompensated HF and poor LV function, the therapeutic success is still extremely limited, resulting in an unacceptably high annual mortality in these patients. Accordingly, heart transplantation, a conventional therapy, could serve as the last resort for these patients. However, the donor of a living heart is extremely lacking, prompting scientists to seek an alternative modality with safety and efficacy. Intriguingly, growing data have demonstrated that cell therapy effectively improved ischemia-related organ dysfunction through tissue regeneration, angiogenesis, anti-inflammation, and oxidative stress as well as immunomodulation [30, 34-36, 38, 40, 41]. One important finding in the present study was that as compared with DCM animals, the LVEF (i.e., the heart function) was significantly preserved in iPS-MSCs treated DCM animals. Our finding corroborated with the finding of the previous studies [30, 34-36, 38, 40, 41]. The most important finding in the present study was that iPS-MSC dOex-mIRs was expected superior to iPS-MSCs for improving the LVEF in DCM rodent. As we expected, our finding, in addition to the extension of the previous studies, highlights that this strategic management may pose a therapeutic potential for those DCM patients with decompensated HF and poorest heart function with requirement of heart transplantation.
It is always a universal concept that prior to offering an effective treatment for a specific disease, the delineation of the underlying mechanism of the disease entity is of utmost importance. An important finding in the present study was that the signaling pathway of oxidative stress, mitochondrial damaged ,and apoptotic biomarkers as well as the downstream members of the MAPK family were identified to be markedly enhanced in DCM animals (refer to Fig. 11). Of particular importance was that not only the in vitro but also the in vivo studies demonstrated that the upregulated oxidative-stress signaling further elicited the mitochondrial damage, apoptosis, and autophagic activity in iPS-MSC treated by H 2 O 2 and DCM myocardium. Intriguingly, previous studies have also clearly identified that these aforementioned molecular-cellular perturbations were remarkably enhanced in the DCM setting [29,42] and cardiorenal syndrome [43,44] and those of MAPK family members in myocardial ischemia [45]. Accordingly, the findings of the in vitro and in vivo studies, in addition to being consistent with the findings of the previous studies [29,[42][43][44], could, at least in part, explain why the LVEF was substantially reduced in DCM animals than in those of SC animals. Abundant data have revealed that inflammatory activation was frequently elicited in DCM myocardium [29,42], acute myocardial infarction [45], and cardiorenal syndrome [43,44], which in turn led to progressively cardiomyocyte apoptosis and death, resulting in myocardial fibrosis and deteriorating heart function [29,[42][43][44][45]. A principal finding in the present study was that not only the upstream but also the downstream inflammatory signalings in the DCM setting were clearly delineated (refer to Fig. 8). In this way, our findings, in addition to strengthening the findings of previous studies [29,[42][43][44][45], further identified that the underlying signaling pathway of DCM was complex and probably involved in multiple signaling pathways (i.e., inflammation, oxidative stress, MAPK family, and autophagy) (refer to Figs. 8 and 11). Of particularly distinctive finding was that iPS-MSC dOex-mIRs treatment was superior to iPS-MSCs treatment for improving LVEF in DCM animals.
Perhaps, the readers would be interesting not only in the exactly underlying mechanisms of DCM but much more interesting in the mechanistic basis of how iPS-MSCs and iPS-MSC dOex-mIRs treatment on improving the rat heart function. In our schematically proposed mechanisms of Figs. 8 and 11, we clearly delineated that the iPS-MSCs and iPS- MSC dOex-mIRs treatment on successful preservation of the heart function was mainly through suppressing the upstream and downstream inflammatory, cell-stress and oxidative-stress signalings to avoid the mitochondrial damage, cell apoptosis, DNA damage, and myocardial fibrosis in DCM rodent.

Study limitation
This study has limitations. First, although the study period was 60 days, the longer-term impact of iPS-MSCs/ iPS-MSC dOex-mIRs on preservation of the left ventricular function is still currently uncertain. Second, in the absence of applying 2 nd iPS-MSC dOex-mIRs , whether a 2nd therapy would offer additional benefit on furthermore improving the cardiac function in those DCM animals remains to be answered.
In conclusion, as compared to the iPS-MSCs therapy iPS-MSC dOex-mIRs therapy offered additional benefits on improving the LVEF in DCM animals.

Conclusion
iPS-MSC dOex-mIRs therapy was superior to iPS-MSC therapy for preserving LV function in DCM rat.